Alexis Dormandy, Oxford Science Enterprises CEO

Ox­ford Sci­ence En­ter­pris­es col­lects $300M to of­fer spin­outs 's­cale-up cap­i­tal'

For the past sev­en years, biotech spin­outs from the Uni­ver­si­ty of Ox­ford have of­ten tapped in­to a re­li­able source of in­vest­ments from Ox­ford Sci­ence En­ter­pris­es …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.